Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Change in Accured Expenses (2021 - 2025)

Prime Medicine filings provide 5 years of Change in Accured Expenses readings, the most recent being $1.6 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 1211.11% to $1.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 million, a 162.94% decrease, with the full-year FY2025 number at -$1.2 million, down 162.94% from a year prior.
  • Change in Accured Expenses hit $1.6 million in Q4 2025 for Prime Medicine, up from -$1.1 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $33.3 million in Q4 2021 to a low of -$33.3 million in Q1 2022.
  • Median Change in Accured Expenses over the past 5 years was $890000.0 (2022), compared with a mean of $581058.8.
  • The widest YoY moves for Change in Accured Expenses: up 1211.11% in 2025, down 118.06% in 2025.
  • Prime Medicine's Change in Accured Expenses stood at $33.3 million in 2021, then crashed by 87.73% to $4.1 million in 2022, then tumbled by 38.53% to $2.5 million in 2023, then tumbled by 105.73% to -$144000.0 in 2024, then surged by 1211.11% to $1.6 million in 2025.
  • The last three reported values for Change in Accured Expenses were $1.6 million (Q4 2025), -$1.1 million (Q3 2025), and $5.0 million (Q2 2025) per Business Quant data.